A Cox regression model was used to investigate the association of these risk factors with the incidence of total cardiac arrhythmia in the presence of SGLT2 inhibitor therapy, and the results are listed in Table 2. The gene discussed is SLC5A2; the disease is chronic obstructive pulmonary disease.